CGHS

Generic medicines in India face scrutiny as the CDSCO grapples with substandard drugs, lack of human resources, state data blackouts, and MSME violations.

CGHS Crisis: Faulty generic drugs cause adverse reactions for beneficiaries, revealing flaws in the 2023 government circular and systemic healthcare failures.